Evidence map›Paper›PMID 41315515›Full record

ArticleScientific reports2025

Survival machine learning models for predicting all-cause and case-specific mortality risk in metabolic dysfunction-associated fatty liver disease patients.

Jingpeng Gao, Nan Zhang, Akemujiang Aximu, Ning Xin, Ziwei Wang, Ping Yan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingpeng Gao *Department of Infectious Disease, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China.
Nan Zhang *State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, Xinjiang, China.
Akemujiang AximuDepartment of Infectious Disease, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China.
Ning XinDepartment of Thoracic Surgery, PLA 960th Hospital, Jinan, Shandong, China.
Ziwei WangEmergency Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Ping YanSchool of Nursing, Xinjiang Medical University, Urumqi, Xinjiang, China. yanping@xjmu.edu.cn.

Funding

Regional Collaborative Innovation Special Project of Autonomous Region - Science and Technology Aid Xinjiang Plan 2022E02119State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases Fund SKL-HIDCA-2023-HL-12Xinjiang Medical University Intelligent Aging Care and Integrative Care for Older Adults Innovation Research Team XYD2024C06
6 · The paper itself

Abstract

Emerging evidence links metabolic dysfunction-associated fatty liver disease (MAFLD) with increased all-cause and circulatory system disease (CSD) mortality in adults, yet survival machine learning studies are limited. This study analyzed 4415 NHANES participants with MAFLD to predict mortality using five survival models, and further, the optimal models were selected to identify the most significant predictors of mortality. Machine learning models proved highly effective in prediction. The Gradient Boosted Survival (GBS) model performed best for all-cause mortality, while Extra Survival Trees (EST) excelled for CSD mortality. The Shapley Additive Explanations (SHAP) analyses revealed that the five clinical factors most strongly associated with all-cause mortality were age, gender, platelet count, high-density lipoprotein cholesterol, and smoking status. For CSD mortality, the key factors associated with increased risk were age, blood urea nitrogen, systolic blood pressure, history of heart attack, and gender. Subgroup analyses confirmed GBS and Cox proportional hazard (CoxPH) were optimal for middle-aged and older all-cause mortality, whereas Elastic Net-regularized Cox proportional hazard (CoxNet) was best for older CSD mortality. The findings demonstrate that survival machine learning models effectively predict mortality risk in MAFLD patients. Integrating these models with permutation importance and SHAP provides transparent insights into individual risk profiles, enabling clinicians to clearly interpret how key variables contribute to predictions and improve risk stratification.

Indexed as

Fatty LiverMachine LearningAdultAgedCause of DeathFemaleHumansMaleMiddle AgedProportional Hazards ModelsRisk FactorsInterpretable machine learningMetabolic dysfunction-associated fatty liver diseasesMortalityPredictive modelSHAP value

Identifiers

PMID41315515
PMCPMC12663551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.